IPSC vs TFC · rev $6.6M vs rev $24.54B
Century Therapeutics Inc (IPSC) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
TFC (TFC) common stock.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
IPSC currently screens at market cap $47.8M. TFC currently screens at market cap $0.
Not investment advice. Open the IPSC and TFC stock pages for the full models.
Not investment advice.